International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Thyroid Potency Calculations

Author(s): Stack Bob

Issue: Jul/Aug 2010 - Sterile Compounding
View All Articles in Issue

Page(s): 306-309

Download in electronic PDF format for $75

Abstract: The United States Pharmacopeia defines the label strength for Levothyroxine Sodium USP, Liothyronine Sodium USP, and Thyroid Powder USP. These powders need a certificate of analysis for potency calculations. This article is an explanation of the calculations involved to achieve the correct United States Pharmacopeia label strength for thyroid hormones.

Related Keywords: Bob Stack, RPh, thyroid hormones T4 T3, levothyroxine sodium, liothyronine sodium, certificates of analysis, thyroid USP, potency analysis

Related Categories: QUALITY CONTROL, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Thyroid Potency Calculations Stack Bob	Jul/Aug 2010 Pg. 306-309
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3) Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N	Sep/Oct 2017 Pg. 418-425
Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol Snyder Scott, Listecki Robert E	Sep/Oct 2012 Pg. 376-380
Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules Allen Loyd V Jr	Nov/Dec 2008 Pg. 545
Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules Allen Loyd V Jr	Nov/Dec 2008 Pg. 547
Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules Allen Loyd V Jr	Nov/Dec 2008 Pg. 548
Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream Allen Loyd V Jr	Nov/Dec 2008 Pg. 546
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Brunner Scott	Jan/Feb 2023 Pg. 22-23
Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement Milner Martin	Jul/Aug 2005 Pg. 268-273
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 Ford Gina, Garcia Lea	Jan/Feb 2001 Pg. 52-54
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1 Ford Gina, Garcia Lea	Nov/Dec 2000 Pg. 421-422
Basics of Compounding with Dilutions and Concentrates Allen Loyd V Jr	Jan/Feb 2017 Pg. 39-45
Quality Control: Analytical Methods: Why Do I Need a Certificate of Analysis? Zolner William J	May/Jun 2012 Pg. 226-229
Levothyroxine Sodium 100-mcg Capsules Allen Loyd V Jr	Nov/Dec 2013 Pg. 505
Levothyroxine Sodium 40-micro-g/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 247
Standard Operating Procedure: Certificates of Analysis of Materials Used for Pharmaceutical Compounding	Mar/Apr 2001 Pg. 147
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa	Sep/Oct 2015 Pg. 414-419
Wilson's Syndrome and T3 Therapy Milner Martin	Sep/Oct 1999 Pg. 344-348
The Role of Sex Hormones on Fibromyalgia Pain Mediators Bramwell Bethany L	May/Jun 2010 Pg. 193-199
Basics of Compounding: Basics of Compounding with Potency Designated Ingredients Allen Loyd V Jr	Jan/Feb 2011 Pg. 56-61
Return to Top